Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2− Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice

Abstract Introduction Hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) is the most frequently diagnosed metastatic breast cancer (mBC) subtype. Combinations of endocrine therapy (ET) with cyclin-dependent kinase 4/6 inhibitors (CDK4 & 6is) improve outcome...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Alistair Ring (Egilea), Meghan Karuturi (Egilea), Emily Nash Smyth (Egilea), Tasneem Lokhandwala (Egilea), Kristin M. Sheffield (Egilea), Joanne Willey (Egilea), Orsolya Lunacsek (Egilea), Francisco Sapunar (Egilea), Zhanglin Lin Cui (Egilea), Anna D. Coutinho (Egilea), Sarah Rybowski (Egilea)
Formatua: Liburua
Argitaratua: Adis, Springer Healthcare, 2023-09-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

Connect to this object online.

3rd Floor Main Library

Aleari buruzko argibideak 3rd Floor Main Library
Sailkapena: A1234.567
Alea 1 Eskuragarri